LITE Surpasses All EstimatesBut Holding After Earnings Backfired

Lumentum Holdings (LITE) reported Q2 fiscal 2026 earnings on Feb 3, 2026, with revenue surging 65.5% year-over-year to $665.50 million and a net income turnaround of 228.4% to $78.20 million. The company exceeded both EPS and revenue estimates, with guidance for Q3 indicating a 85% year-over-year revenue growth outlook.

Revenue

Components revenue surged to $443.70 million, while systems revenue reached $221.80 million, contributing to the total revenue of $665.50 million. The performance was driven by strong demand for cloud transceivers, optical circuit switches (OCS), and co-packaged optics (CPO), with OCS exceeding internal expectations and a $400 million backlog slated for late 2026/early 2027.

Earnings/Net Income

Lumentum returned to profitability with EPS of $1.10, reversing from a loss of $0.88 per share in Q2 2025. Net income rose to $78.20 million, reflecting a 228.4% positive swing from the prior year’s net loss. The company’s remarkable turnaround underscores its strong Q2 performance.

Price Action

The stock price dropped 3.68% during the latest trading day but surged 17.39% in the most recent week and 18.04% month-to-date.

Post-Earnings Price Action Review

The strategy of buying LITE when revenues beat expectations and holding for 30 days resulted in a significant underperformance. The strategy returned -36.39%, while the benchmark returned 64.50%, highlighting an excess return of -100.89% and a CAGR of -9.37%.

CEO Commentary

CEO Michael Hurlston highlighted record revenue driven by 65% YoY growth, with OCS and CPO as core drivers. He emphasized a $400 million OCS backlog and multi-hundred-million-dollar CPO orders, positioning Lumentum to scale complex technologies while maintaining margin expansion.

Guidance

Lumentum guided Q3 2026 revenue to $780–830 million (midpoint $805 million, +85% YoY), non-GAAP operating margin of 30–31%, and diluted EPS of $2.15–2.35. Strategic priorities include capacity expansion and leveraging long-term supply agreements to meet surging demand.

Additional News

Lumentum’s stock surged 10.6% post-earnings amid AI-driven demand and robust guidance. Analysts at Morgan Stanley maintained an Equal-Weight rating with a $350 price target, while Benzinga highlighted LITE’s 416% 12-month gain and strong momentum. The company’s optical scale-up technology, targeting late 2027 shipments, is positioned as a “generational game changer,” further bolstering investor optimism.